🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK NHS GLP-1 prescribing — 12 month update Page 4

UK NHS GLP-1 prescribing — 12 month update

emily_PDX Mon, Oct 20, 2025 at 1:29 AM 28 replies 1,548 viewsPage 4 of 6
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Oct 25, 2025 at 4:22 PM#16

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

10 10pete_nash, hank_denver, carlos_SATX and 7 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Oct 26, 2025 at 12:47 PM#17
lucas_SP_BR said:
If you are going to change something, change one thing and give it long enough to express itself.

There is a second half to this that has not been said yet. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

I would rather be corrected than agreed with, if it comes to it.

9 9bri_stats, pete_manc_UK, anna.melb_AU and 6 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Oct 27, 2025 at 9:13 AM#18

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

8 8SteveThurs, B12Beth, RickReta_CO and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Oct 28, 2025 at 5:39 AM#19

Following on from lucas_SP_BR — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

Last edited: Oct 28, 2025 at 11:39 AM
7 7labquiet_amy, emily_PDX, Dr.SleepRoch and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 29, 2025 at 2:06 AM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Tagging this one for the weekly digest.

35 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 32 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register